{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:10Z","timestamp":1792008070800,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Polypharmacy and long-term preventive medication use are common in frail older adults with limited life expectancy, despite uncertain benefits and potential risks. This systematic review and meta-analysis synthesized evidence on the effect of deprescribing preventive medications (antihypertensives, statins, anticoagulants, and antidiabetic agents) compared to continuation on clinical, physiological, safety, and patient-centered outcomes among older adults with advanced frailty, dementia, or limited life expectancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Cochrane Library, Web of Science, CINAHL, and ProQuest Dissertations &amp; Theses Global were searched for eligible randomized controlled trials and observational studies. The primary outcome was all-cause mortality. Secondary outcomes were hospitalization, major adverse cardiovascular events (MACE), changes in blood pressure, risks of fractures and falls, and quality of life. Data were pooled (relative risk [RR] or mean difference or standardized mean difference) using random-effects models (RevMan version 5.4). The evidence certainty was evaluated by the GRADE framework (PROSPERO ID: CRD420251147086).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 10,397 records, 15 studies (&gt;\u200933,000 participants) were included. Overall, deprescribing was not associated with increased risk of all-cause mortality (RR: 1.15, 95% CI: 0.98\u20131.35, I\n                      <jats:sup>2<\/jats:sup>\n                      : 93%), hospitalization (RR: 0.93, 95% CI: 0.82\u20131.07, I\n                      <jats:sup>2<\/jats:sup>\n                      : 68%), or MACE (RR: 1.37, 95% CI: 0.70\u20132.70, I\n                      <jats:sup>2<\/jats:sup>\n                      : 95%) (certainty: very low GRADE). Deprescribing was also not associated with increased risks of fracture, fall, or deterioration of quality of life, but with slightly increased systolic blood pressure (deprescribing antihypertensives).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Deprescribing preventive medications in frail or palliative older adults was not associated with worse outcomes; however, evidence certainty was very low, and further studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-026-07354-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:05:22Z","timestamp":1773709522000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Deprescribing preventive medications in older adults with advanced frailty, dementia, or limited life expectancy: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Saibal","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrushali","family":"Shendage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanay","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir","family":"Bhatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarnendu","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Aadityan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepasree","family":"Sukumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanskriti","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiran","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu Kumar","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia St\u00e5lsby","family":"Lundborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"7354_CR1","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1038\/s41598-024-84627-2","volume":"15","author":"S Das","year":"2025","unstructured":"Das S, Gnanavel P, Smanla S, et al. Polypharmacy and self-medication among older adults in Indian urban communities\u2014a cross-sectional study. Sci Rep. 2025;15:4062.","journal-title":"Sci Rep"},{"key":"7354_CR2","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/jgs.13153","volume":"62","author":"TR Fried","year":"2014","unstructured":"Fried TR, O\u2019Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261\u201372.","journal-title":"J Am Geriatr Soc"},{"key":"7354_CR3","doi-asserted-by":"crossref","unstructured":"Meraya AM. Preventive Medication Use among Adults Aged 40 and over in the United States: National Health and Nutrition Examination Survey, 2015\u20132018. Healthcare (Basel). 2022;10:1875.","DOI":"10.3390\/healthcare10101875"},{"key":"7354_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. J Am Med Dir Assoc. 2020;21:181\u20137.","journal-title":"J Am Med Dir Assoc"},{"key":"7354_CR5","doi-asserted-by":"publisher","first-page":"ckaf1611180","DOI":"10.1093\/eurpub\/ckaf161.1180","volume":"35","author":"S Das","year":"2025","unstructured":"Das S, Shukla S, Aadityan R, et al. Interventions to optimize medication management in elderly: An umbrella review of systematic reviews. Eur J Public Health. 2025;35:ckaf1611180.","journal-title":"Eur J Public Health"},{"key":"7354_CR6","doi-asserted-by":"publisher","first-page":"e0305215","DOI":"10.1371\/journal.pone.0305215","volume":"19","author":"S Chua","year":"2024","unstructured":"Chua S, Todd A, Reeve E, et al. Expert Panel. Deprescribing interventions in older adults: An overview of systematic reviews. PLoS ONE. 2024;19:e0305215.","journal-title":"PLoS ONE"},{"key":"7354_CR7","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.arr.2024.102237","volume":"95","author":"N Veronese","year":"2024","unstructured":"Veronese N, Gallo U, Boccardi V, et al. Efficacy of deprescribing on health outcomes: An umbrella review of systematic reviews with meta-analysis of randomized controlled trials. Ageing Res Rev. 2024;95:102237.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"7354_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1370\/afm.2094","volume":"15","author":"KA Wallis","year":"2017","unstructured":"Wallis KA, Andrews A, Henderson M. Swimming Against the Tide: Primary Care Physicians\u2019 Views on Deprescribing in Everyday Practice. Ann Fam Med. 2017;15(4):341\u20136.","journal-title":"Ann Fam Med"},{"key":"7354_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5195\/jmla.2020.834","volume":"108","author":"JM Clark","year":"2020","unstructured":"Clark JM, Sanders S, Carter M, et al. Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. J Med Libr Assoc. 2020;108:195\u2013207.","journal-title":"J Med Libr Assoc"},{"key":"7354_CR10","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"7354_CR11","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"7354_CR12","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. Available from: Cochrane Handbook for Systematic Reviews of Interventions | Cochrane (accessed 4 Oct 2025)."},{"key":"7354_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"7354_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","volume":"66","author":"J Andrews","year":"2013","unstructured":"Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719\u201325.","journal-title":"J Clin Epidemiol"},{"key":"7354_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","volume":"66","author":"JC Andrews","year":"2013","unstructured":"Andrews JC, Sch\u00fcnemann HJ, Oxman AD, et al. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation\u2019s direction and strength. J Clin Epidemiol. 2013;66:726\u201335.","journal-title":"J Clin Epidemiol"},{"key":"7354_CR16","doi-asserted-by":"publisher","unstructured":"Benetos A, Gautier S, Freminet A, RETREAT-FRAIL Study Group, et al. Reduction of Antihypertensive Treatment in Nursing Home Residents. N Engl J Med. 2025 Aug;29. https:\/\/doi.org\/10.1056\/NEJMoa2508157.","DOI":"10.1056\/NEJMoa2508157"},{"key":"7354_CR17","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1111\/jth.13427","volume":"14","author":"G Bertozzo","year":"2016","unstructured":"Bertozzo G, Zoppellaro G, Granziera S, et al. Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation. J Thromb Haemost. 2016;14:2124\u201331.","journal-title":"J Thromb Haemost"},{"key":"7354_CR18","doi-asserted-by":"publisher","first-page":"E1198","DOI":"10.1503\/cmaj.220919","volume":"194","author":"N Chin-Yee","year":"2022","unstructured":"Chin-Yee N, Gomes T, Tanuseputro P, Talarico R, Laupacis A. Deprescribing of anticoagulants in home palliative care patients: a population-based cohort study. CMAJ. 2022;194:E1198\u2013208.","journal-title":"CMAJ"},{"key":"7354_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jgs.16278","volume":"68","author":"D Curtin","year":"2020","unstructured":"Curtin D, Jennings E, Daunt R, Randles M, Gallagher P, O\u2019Mahony D. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail. Criteria J Am Geriatr Soc. 2020;68:762\u20139.","journal-title":"Criteria J Am Geriatr Soc"},{"key":"7354_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12877-018-0892-2","volume":"18","author":"C Gulla","year":"2018","unstructured":"Gulla C, Flo E, Kjome RL, et al. Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure, cognition and quality of life: the COSMOS study. BMC Geriatr. 2018;18:199.","journal-title":"BMC Geriatr"},{"key":"7354_CR21","first-page":"1997","volume":"85","author":"BS Huseb\u00f8","year":"2019","unstructured":"Huseb\u00f8 BS, Flo E, Aarsland D, et al. Multicomponent intervention to reduce the use of potentially inappropriate medications in nursing homes (COSMOS): cluster randomized trial. Br J Clin Pharmacol. 2019;85:1997\u20132008.","journal-title":"Br J Clin Pharmacol"},{"issue":"37","key":"7354_CR22","doi-asserted-by":"publisher","first-page":"e26966","DOI":"10.1097\/MD.0000000000026966","volume":"100","author":"M Ioffe","year":"2021","unstructured":"Ioffe M, Kremer A, Nachimov I, Swartzon M, Justo D. Mortality associated with stopping statins in the oldest-old - with and without ischemic heart disease. Med (Baltim). 2021;100(37):e26966.","journal-title":"Med (Baltim)"},{"key":"7354_CR23","first-page":"401","volume":"125","author":"EK Kempers","year":"2025","unstructured":"Kempers EK, Visser C, Geijteman ECT, et al. Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease. Thromb Haemost. 2025;125:401\u201311.","journal-title":"Thromb Haemost"},{"key":"7354_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","volume":"175","author":"JS Kutner","year":"2015","unstructured":"Kutner JS, Blatchford PJ, Taylor DH Jr, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175:691\u2013700.","journal-title":"JAMA Intern Med"},{"key":"7354_CR25","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1001\/jamainternmed.2015.4103","volume":"175","author":"JEF Moonen","year":"2016","unstructured":"Moonen JEF, Foster-Dingley JC, de Ruijter W, et al. Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning - the DANTE Study Leiden: a randomized clinical trial. JAMA Intern Med. 2016;175:1622\u201330.","journal-title":"JAMA Intern Med"},{"key":"7354_CR26","doi-asserted-by":"crossref","first-page":"afad012","DOI":"10.1093\/ageing\/afad012","volume":"52","author":"A Mortsiefer","year":"2023","unstructured":"Mortsiefer A, Junius-Walker U, Ose D, et al. Impact of a general practitioner-based deprescribing intervention in frail older patients with polypharmacy: results from the COFRAIL cluster randomized trial. Age Ageing. 2023;52:afad012.","journal-title":"Age Ageing"},{"key":"7354_CR27","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/jgs.17437","volume":"70","author":"JD Niznik","year":"2022","unstructured":"Niznik JD, Zhao X, Bynum JPW, Thorpe CT, Hanlon JT. Deintensification of diabetes medications among nursing home residents with limited life expectancy or advanced dementia. J Am Geriatr Soc. 2022;70:1720\u201331.","journal-title":"J Am Geriatr Soc"},{"key":"7354_CR28","first-page":"709","volume":"82","author":"K Potter","year":"2016","unstructured":"Potter K, Flicker L, Page A, et al. Deprescribing in frail older people: randomized controlled trial of a patient-centered medication review. Br J Clin Pharmacol. 2016;82:709\u201319.","journal-title":"Br J Clin Pharmacol"},{"key":"7354_CR29","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jama.2020.4871","volume":"323","author":"JP Sheppard","year":"2020","unstructured":"Sheppard JP, Burt J, Lown M, et al. Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in older patients: the OPTiMISE randomized clinical trial. JAMA. 2020;323:2039\u201351.","journal-title":"JAMA"},{"key":"7354_CR30","first-page":"1123","volume":"83","author":"JP Sheppard","year":"2024","unstructured":"Sheppard JP, Burt J, McManus RJ, et al. Long-term outcomes of antihypertensive medication reduction in older adults: extended follow-up of the OPTiMISE randomized clinical trial. Hypertension. 2024;83:1123\u201332.","journal-title":"Hypertension"},{"key":"7354_CR31","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47:S179-S218.","DOI":"10.2337\/dc24-S010"},{"key":"7354_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/psyg.12073","volume":"14","author":"S Ghosh","year":"2014","unstructured":"Ghosh S, Bandyopadhyay S, Bhattacharya S, et al. Quality of life of older people in an urban slum of India. Psychogeriatrics. 2014;14:241\u20136.","journal-title":"Psychogeriatrics"},{"key":"7354_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12916-020-01774-9","volume":"18","author":"A Hodkinson","year":"2020","unstructured":"Hodkinson A, Tyler N, Ashcroft DM, et al. Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Med. 2020;18:313.","journal-title":"BMC Med"},{"key":"7354_CR34","doi-asserted-by":"publisher","first-page":"e259375","DOI":"10.1001\/jamanetworkopen.2025.9375","volume":"8","author":"AM Linsky","year":"2025","unstructured":"Linsky AM, Motala A, Booth M, et al. Deprescribing in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2025;8:e259375.","journal-title":"JAMA Netw Open"},{"key":"7354_CR35","doi-asserted-by":"crossref","unstructured":"Zhou D, Chen Z, Tian F. Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2023;24(11):1718\u20131725. Erratum in: J Am Med Dir Assoc. 2024;25(11):105305.","DOI":"10.1016\/j.jamda.2024.105305"},{"key":"7354_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/14740338.2021.1853704","volume":"20","author":"M Cardona","year":"2021","unstructured":"Cardona M, Stehlik P, Fawzy P, et al. Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review. Expert Opin Drug Saf. 2021;20:81\u201391.","journal-title":"Expert Opin Drug Saf"},{"key":"7354_CR37","doi-asserted-by":"crossref","unstructured":"Shrestha R, Shaw E, Mullen L, Sinclair D, Dewhurst F, Todd A. Outcomes of deprescribing for people with life-limiting conditions: A systematic review. Palliat Med. 2026 Feb;22:2692163261416281.","DOI":"10.1093\/ageing\/afaf368.164"},{"issue":"10","key":"7354_CR38","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/bcp.14113","volume":"86","author":"S Shrestha","year":"2020","unstructured":"Shrestha S, Poudel A, Steadman K, et al. Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: A systematic review. Br J Clin Pharmacol. 2020;86(10):1931\u201345.","journal-title":"Br J Clin Pharmacol"},{"key":"7354_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"9868","key":"7354_CR40","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752\u201362.","journal-title":"Lancet"},{"key":"7354_CR41","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1210\/jc.2019-00198","volume":"104","author":"D LeRoith","year":"2019","unstructured":"LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104:1520\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"7354_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.18773\/austprescr.2024.023","volume":"47","author":"E Reeve","year":"2024","unstructured":"Reeve E, Gnjidic D, Langford AV, et al. Deprescribing antihypertensive drugs in frail older adults. Aust Prescr. 2024;47:85\u201390.","journal-title":"Aust Prescr"},{"key":"7354_CR43","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1007\/s11357-023-00852-z","volume":"45","author":"E Hickman","year":"2023","unstructured":"Hickman E, Seawoodharry M, Gillies C, et al. Deprescribing in cardiometabolic conditions in older patients: a systematic review. Geroscience. 2023;45:3491\u2013512.","journal-title":"Geroscience"},{"key":"7354_CR44","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1186\/s12877-023-04444-6","volume":"23","author":"C Yang","year":"2023","unstructured":"Yang C, Zhu S, Hui Z. Psychosocial factors associated with medication burden among community-dwelling older people with multimorbidity. BMC Geriatr. 2023;23:741.","journal-title":"BMC Geriatr"},{"key":"7354_CR45","doi-asserted-by":"publisher","first-page":"e2336728","DOI":"10.1001\/jamanetworkopen.2023.36728","volume":"6","author":"JD Norton","year":"2023","unstructured":"Norton JD, Zeng C, Bayliss EA, et al. Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia. JAMA Netw Open. 2023;6:e2336728.","journal-title":"JAMA Netw Open"},{"key":"7354_CR46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bcp.12975","volume":"82","author":"AT Page","year":"2016","unstructured":"Page AT, Clifford RM, Potter K, et al. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82:583\u2013623.","journal-title":"Br J Clin Pharmacol"},{"key":"7354_CR47","doi-asserted-by":"publisher","first-page":"105465","DOI":"10.1016\/j.archger.2024.105465","volume":"124","author":"S Kim","year":"2024","unstructured":"Kim S, Lee H, Park J, et al. Global and regional prevalence of polypharmacy and related factors, 1997\u20132022: An umbrella review. Arch Gerontol Geriatr. 2024;124:105465.","journal-title":"Arch Gerontol Geriatr"},{"key":"7354_CR48","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.joclim.2025.100427","volume":"23","author":"LHJA Kouwenberg","year":"2025","unstructured":"Kouwenberg LHJA, Kringos DS, Hehenkamp WJK, et al. The interplay of factors influencing the carbon footprint of hospital care-A causal mapping analysis of scientific reports. J Clim Chang Health. 2025;23:100427.","journal-title":"J Clim Chang Health"},{"issue":"6","key":"7354_CR49","first-page":"173","volume":"12","author":"G Parker","year":"2024","unstructured":"Parker G, Miller FA. Tackling Pharmaceutical Pollution Along the Product Lifecycle: Roles and Responsibilities for Producers, Regulators and Prescribers. Pharm (Basel). 2024;12(6):173.","journal-title":"Pharm (Basel)"},{"key":"7354_CR50","unstructured":"Perry T, editor. Therapeutics Letter. Vancouver (BC): Therapeutics Initiative; 1994-. Letter 143, Reducing the adverse environmental impacts of prescribing. 2023 Jun. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK608179\/ (accessed 28 Feb 2026)."},{"key":"7354_CR51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.14283\/jfa.2019.29","volume":"8","author":"M Kiiti Borges","year":"2019","unstructured":"Kiiti Borges M, Oiring de Castro Cezar N, Silva Santos Siqueira A, et al. The Relationship between Physical Frailty and Mild Cognitive Impairment in the Elderly: A Systematic Review. J Frailty Aging. 2019;8:192\u20137.","journal-title":"J Frailty Aging"},{"key":"7354_CR52","doi-asserted-by":"publisher","first-page":"P338","DOI":"10.1093\/geronb\/57.4.P338","volume":"57","author":"J Ormel","year":"2002","unstructured":"Ormel J, Rijsdijk FV, Sullivan M, et al. Temporal and reciprocal relationship between IADL\/ADL disability and depressive symptoms in late life. J Gerontol B Psychol Sci Soc Sci. 2002;57:P338\u201347.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"7354_CR53","doi-asserted-by":"publisher","first-page":"11343","DOI":"10.1038\/s41598-019-47731-2","volume":"9","author":"IMJ Kant","year":"2019","unstructured":"Kant IMJ, Mutsaerts HJMM, van Montfort SJT, et al. BioCog Consortium. The association between frailty and MRI features of cerebral small vessel disease. Sci Rep. 2019;9:11343.","journal-title":"Sci Rep"},{"key":"7354_CR54","first-page":"k5432","volume":"363","author":"D Mangin","year":"2018","unstructured":"Mangin D, Bahat G, Golomb BA, et al. Deprescribing: a pragmatic approach to reducing polypharmacy in older adults. BMJ. 2018;363:k5432.","journal-title":"BMJ"},{"key":"7354_CR55","doi-asserted-by":"publisher","first-page":"e2350963","DOI":"10.1001\/jamanetworkopen.2023.50963","volume":"7","author":"MS Keller","year":"2024","unstructured":"Keller MS, Qureshi N, Mays AM, Sarkisian CA, Pevnick JM. Cumulative Update of a Systematic Overview Evaluating Interventions Addressing Polypharmacy. JAMA Netw Open. 2024;7:e2350963.","journal-title":"JAMA Netw Open"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07354-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:14:46Z","timestamp":1781640886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07354-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7354"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07354-5","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"579"}}